Medical Polyoxymethylene Market, By Type (Homopolymer POM, Copolymer POM), By Medical Application (Dialysis Machine, Handles for Surgical Instruments, Inhalers, Insulin Pen, Medical Trays, Pharmaceutical Closures, Other Medical Applications)-

Published In : Apr 2023

Code : CMI5655

Pages :122

Formats :

Excel and PDF

Industry : Bulk Chemicals

Market Challenges And Opportunities

Global Medical Polyoxymethylene (POM) Market Drivers:

Growing demand for drug contact and delivery applications to augment market growth

Continuous innovation in the field of drug delivery systems market is driving growth of the medical POM market. For instance, in January of 2019, the Polyplastics Group announced the development of the DURACON(R) polyoxymethylene (POM) PM series for drug contact and delivery applications for the medical/healthcare market. The new PM series complements the company’s TOPAS(R) cyclic olefin copolymer (COC), a high-purity material for a range of medical applications.

Expanding medical devices industry to foster market growth

POM is common medical plastic, which is widely used in the manufacturing of a wide range of medical devices such as intraocular lenses, bone cement, cranial implants, etc. This material has a strong elastomeric property and can regain its original shape and size after being stretched. It is a popular choice for making prosthetics because it can be easily processed and it is reusable, which helps reduce the cost of production.

Global Medical Polyoxymethylene (POM) Market Opportunities:

Increasing replacement of metal with POM is expected to provide significant growth opportunities. POM, which is short for polyoxymethylene, is a chemically engineered thermoplastic resin that has several properties, which make it suitable to replace metal in the production of many medical devices. It has a high-molecular weight, good dimensional stability and is resistant to moisture absorption. It is also known for its high tensile strength, rigidity and durability.

Growing number of R &D in the field of medical POM is expected to serve major growth opportunities. For instance, in January 2019, the Polyplastics Group has announced the development of the DURACON® polyoxymethylene (POM) PM series for drug contact and delivery applications for the medical/healthcare market. The new PM series complements Polyplastics’ TOPAS® cyclic olefin copolymer (COC), a high-purity material for a range of medical applications.